您的位置: 首页 > 农业专利 > 详情页

COMPOSITIONS AND METHODS BASED ON NEUTRALIZING ANTIBODIES DELIVERED INTRANASALLY FOR IMPROVED THERAPEUTIC EFFECTIVENESS
专利权人:
KONTRAFEKT KORPOREJSHN
发明人:
VITTEKIND Majkl (US),ВИТТЕКИНД Майкл (US),VIGIL Adam (US),ВИГИЛ Адам (US)
申请号:
RU2015136392
公开号:
RU0002701694C2
申请日:
2014.03.14
申请国别(地区):
RU
年份:
2019
代理人:
摘要:
FIELD: biotechnology.SUBSTANCE: invention relates to the biotechnology. Described is a composition for respiratory delivery, obtained and effective for treating and/or preventing infection of influenza virus in a mammal, containing two or more influenza virus-neutralizing monoclonal antibodies in the form of a single dose and in an effective amount of 0.005 mg/kg to 1 mg/kg and a suitable pharmaceutically acceptable carrier, diluent or excipient, where at least a first antibody is directed against influenza virus A of one subtype, and at least a second antibody is directed against influenza A virus of another subtype than said first antibody, or against influenza virus B, or there are at least two second antibodies, one of which is directed against influenza A virus of said other subtype and the other antibody is directed against influenza B virus. Described is a method of treating or preventing influenza virus in a mammal using said composition. Presented is a preventive and therapeutic combination comprising: a first composition prepared for intranasal or inhalation administration, containing two or more influenza virus-neutralizing monoclonal antibodies in the form of a single dose of 0.005 mg/kg to 1 mg/kg against influenza viruses having different specificity, and a second composition prepared for intraperitoneal or intravenous administration, containing one or more influenza antibodies in the form of a single dose of 1 mg/kg to 10 mg/kg, where one or more antibodies in the second composition are the same as one or more antibodies in the first composition, or other antibodies. Disclosed is a method for reducing transmission of influenza virus, involving administering said composition intranasally or inhalation to a subject exposed, at risk of exposure to influenza virus or exhibiting clinical signs of infection with influenza virus.EFFECT: invention extends the range of products for treating and preventing influenza.37 cl, 38 dwg, 2 tbl, 11 exИзобретение относи
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充